CN114568706A - 一种醒酒复合肽及其制备方法 - Google Patents
一种醒酒复合肽及其制备方法 Download PDFInfo
- Publication number
- CN114568706A CN114568706A CN202210141182.9A CN202210141182A CN114568706A CN 114568706 A CN114568706 A CN 114568706A CN 202210141182 A CN202210141182 A CN 202210141182A CN 114568706 A CN114568706 A CN 114568706A
- Authority
- CN
- China
- Prior art keywords
- parts
- peptide
- bean
- sobering
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 202
- 150000001875 compounds Chemical class 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title description 5
- 239000002131 composite material Substances 0.000 claims abstract description 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 16
- 241000251511 Holothuroidea Species 0.000 claims abstract description 15
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 14
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 14
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 14
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 14
- 235000020232 peanut Nutrition 0.000 claims abstract description 14
- 229920001184 polypeptide Polymers 0.000 claims abstract description 14
- 240000007049 Juglans regia Species 0.000 claims abstract description 13
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 13
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 13
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 13
- 240000004922 Vigna radiata Species 0.000 claims abstract description 13
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 13
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 13
- 240000008042 Zea mays Species 0.000 claims abstract description 13
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 13
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 13
- 235000005822 corn Nutrition 0.000 claims abstract description 13
- 235000020234 walnut Nutrition 0.000 claims abstract description 13
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 12
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 12
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 12
- 244000068988 Glycine max Species 0.000 claims abstract description 12
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 12
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 12
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 12
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 12
- 235000021279 black bean Nutrition 0.000 claims abstract description 12
- 244000013123 dwarf bean Species 0.000 claims abstract description 12
- 235000008397 ginger Nutrition 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 229940082787 spirulina Drugs 0.000 claims abstract description 12
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims abstract description 10
- 102000002068 Glycopeptides Human genes 0.000 claims abstract description 10
- 108010015899 Glycopeptides Proteins 0.000 claims abstract description 10
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 9
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 9
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 238000005303 weighing Methods 0.000 claims abstract description 4
- 206010019133 Hangover Diseases 0.000 claims abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 11
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 11
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 11
- 240000004371 Panax ginseng Species 0.000 claims description 11
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 11
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 11
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 11
- 229940010454 licorice Drugs 0.000 claims description 11
- 240000008397 Ganoderma lucidum Species 0.000 claims description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- ZEDHYTUJIWITOZ-UHFFFAOYSA-N n-(4-acetamidophenyl)-6-chloropyridine-3-carboxamide Chemical group C1=CC(NC(=O)C)=CC=C1NC(=O)C1=CC=C(Cl)N=C1 ZEDHYTUJIWITOZ-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 16
- 210000004185 liver Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 7
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract description 3
- 235000004279 alanine Nutrition 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 206010002091 Anaesthesia Diseases 0.000 abstract description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract description 2
- 238000009825 accumulation Methods 0.000 abstract description 2
- 230000037005 anaesthesia Effects 0.000 abstract description 2
- 235000013922 glutamic acid Nutrition 0.000 abstract description 2
- 239000004220 glutamic acid Substances 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000002249 digestive system Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 3
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 235000012874 Phaseolus calcaratus Nutrition 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000002710 gonadal effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000002311 liver mitochondria Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种醒酒复合肽，按质量份数，其组成包括：甘草肽10‑12份、绿豆肽10‑15份、黑豆肽10‑15份、黄豆肽8‑12份、青豆肽8‑10份、赤小豆肽8‑10份、花生肽3‑5份、核桃肽4‑6份、玉米低聚肽1‑2份、葛根肽3‑5份、人参肽1‑1.5份、灵芝胞外糖肽0.5‑1.2份、海参肽1‑2份、螺旋藻多肽1‑1.5份、生姜肽1‑2份。按各原料所占重量百分数计量称取各种原料，混合均匀，得到醒酒复合肽。肽粉中的丙氨酸和亮氨酸对减轻麻醉、防止酒醉有良好的效果。当然谷氨酸、脯氨酸也对促进酒精的代谢有帮助，只有减少酒精在体内的堆积，减轻其毒性，保护肝脏。
Description
技术领域
本发明涉及食品技术领域，具体涉及一种醒酒复合肽及其制备方法。
背景技术
中国是一个具有深厚酒文化的国家，酒早已成为国民进行社会活动不可缺少的工具。酒精自胃肠道吸收迅速进入血液，在两小时内可100％被吸收。肝脏是代谢酒精的主要器官，酒精经过肝脏中的乙醇脱氢酶(ADH)催化而生成乙醛，乙醛经肝脏线粒体中的乙醛脱氢酶(ALDH)进一步氧化成无毒的乙酸，最终生成二氧化碳和能量。酒精对人体的损害最主要的就是中枢神经***。血液中酒精浓度达到0.05％时，出现兴奋感；达到0.1％时，人会失去自制能力；达到 0.2％时，人已经酩酊大醉；而达到0.4％，人就会失去知觉、昏迷不醒，严重直接面临生命危险。
然而，肝脏氧化代谢酒精的速度很慢，大量饮酒会造成血液中酒精的浓度急剧升高，导致急性酒精中毒即醉酒。急性酒精中毒后，可引起较长时间的不适，出现较长时间的头痛、头晕、失眠、乏力、震颤、胃部不适和恶心，甚至表现为精神迟钝。长期过量饮酒，肝脏易发生蓄积中毒，造成肝损伤。
目前，市面上的醒酒产品组成相对单一，普适性不足，醒酒效果相对弱。
发明内容
本发明所要解决的技术问题是：提供一种易被人体吸收、醒酒效果好的一种醒酒复合肽。
为解决上述技术问题，采用的技术方案为：一种醒酒复合肽，按质量份数，其组成包括：甘草肽10-12份、绿豆肽10-15份、黑豆肽10-15份、黄豆肽8 -12份、青豆肽8-10份、赤小豆肽8-10份、花生肽3-5份、核桃肽4-6份、玉米低聚肽1-2份、葛根肽3-5份、人参肽1-1.5份、灵芝胞外糖肽0.5-1.2 份、海参肽1-2份、螺旋藻多肽1-1.5份、生姜肽1-2份。
优选的，所述的醒酒复合肽中，各种原料的肽数均分子量为200-1500。
进一步优选的，所述的醒酒复合肽中，各种原料的肽数均分子量为 400-800。
所述的一种醒酒复合肽，按质量份数，其组成还包括：低聚木糖3-6份、低聚果糖3-5份。
优选的，所述的一种醒酒复合肽，按质量份数，其组成为：甘草肽10-12 份、绿豆肽13-15份、黑豆肽12-15份、黄豆肽10-12份、青豆肽8-9份、赤小豆肽9-10份、花生肽4-5份、核桃肽4-5份、玉米低聚肽1-1.5份、葛根肽 3-4份、人参肽0.8-1.5份、灵芝胞外糖肽0.5-1份、海参肽1.5-2份、螺旋藻多肽1.2-1.5份、生姜肽1-1.5份、低聚木糖4-5份、低聚果糖3-4份。
进一步优选的，所述的一种醒酒复合肽，按质量份数，其组成为：甘草肽 12份、绿豆肽14份、黑豆肽13份、黄豆肽11份、青豆肽9份、赤小豆肽10 份、花生肽5份、核桃肽4份、玉米低聚肽1.2份、葛根肽4份、人参肽1.2 份、灵芝胞外糖肽0.8份、海参肽2份、螺旋藻多肽1.5份、生姜肽1.2份、低聚木糖4份、低聚果糖3份。
进一步优选的，所述的一种醒酒复合肽，按质量份数，其组成为：甘草肽 11份、绿豆肽13份、黑豆肽15份、黄豆肽12份、青豆肽8份、赤小豆肽9 份、花生肽4份、核桃肽5份、玉米低聚肽1份、葛根肽3份、人参肽1份、灵芝胞外糖肽1份、海参肽1.5份、螺旋藻多肽1.2份、生姜肽1份、低聚木糖5份、低聚果糖4份。
本申请所要解决的第二个技术问题是：一种醒酒复合肽的制备方法，其步骤包括：按各原料所占重量百分数计量称取各种原料，混合均匀，得到醒酒复合肽。
有益效果：
肽粉中的丙氨酸和亮氨酸对减轻麻醉、防止酒醉有良好的效果。当然谷氨酸、脯氨酸也对促进酒精的代谢有帮助，只有减少酒精在体内的堆积，减轻其毒性，保护肝脏。
玉米低聚肽中含有大量以短肽形式存在的丙氨酸和亮氨酸，不需要消化就可以吸收，可快速进入血液循环，增加乙醇脱氢酶和乙醛脱氢酶的活性，促进酒精的代谢和排出，有效降低血液酒精的浓度，缓解酒后头晕、头痛等症状。
绿豆肽中含有丰富的球蛋白和多糖，能促进体内胆固醇在肝脏分解成胆酸，阻止胆汁中有害物质的分泌和吸收；丰富胰蛋白酶则能抑制剂，可以保护肝脏，减少蛋白分解。
花生肽中的维生素B族能加速物质代谢,让它们转化成能量,不仅能给肝脏“加油”,还能修复肝功能、防止肝脂肪变性,进而起到预防脂肪肝的作用，有助于肝脏细胞的新生和调养，调理慢性损伤对肝部的伤害。
核桃肽是小分子物质，可被人体主动、快速吸收，无需消化***进行再次消化，不消耗人体能量，可以极大程度减轻消化***负担；此外，小分子肽能够促进肠道内益生菌的生长，从而保持肠道菌落平衡，提高消化***免疫力，全面提高消化***能力。
海参肽富含聚氨基葡萄糖、粘多糖、海洋生物活性钙、高蛋白、黏蛋白、多肽、胶原蛋白、核酸、海参皂甙、硫酸软骨素、多种维生素、及各种氨基酸和碳水化合物等50多种营养成分。具有延缓衰老的特效，能改善大脑、性腺神经的功能传导作用，提高性腺活力，海参对抗癌有明显疗效，对恶性肿瘤的生长、转移具有显著抑制作用。
具体实施方式
下面对本发明的方法予以进一步地说明，但并不因此而限制本发明。
实施例1
所述的一种醒酒复合肽，其组成为：甘草肽12g、绿豆肽14g、黑豆肽13g、黄豆肽11g、青豆肽9g、赤小豆肽10g、花生肽5g、核桃肽4g、玉米低聚肽 1.2g、葛根肽4g、人参肽1.2g、灵芝胞外糖肽0.8g、海参肽2g、螺旋藻多肽 1.5g、生姜肽1.2g、低聚木糖4g、低聚果糖3g。
实施例2
所述的一种醒酒复合肽，其组成为：甘草肽11g、绿豆肽13g、黑豆肽15g、黄豆肽12g、青豆肽8g、赤小豆肽9g、花生肽4g、核桃肽5g、玉米低聚肽1g、葛根肽3g、人参肽1g、灵芝胞外糖肽1g、海参肽1.5g、螺旋藻多肽1.2g、生姜肽1g、低聚木糖5g、低聚果糖4g。
实施例3
所述的一种醒酒复合肽，其组成为：甘草肽10g、绿豆肽15g、黑豆肽15g、黄豆肽10g、青豆肽8g、赤小豆肽9.5g、花生肽4g、核桃肽5g、玉米低聚肽 1.5g、葛根肽3.5g、人参肽1.5g、灵芝胞外糖肽1g、海参肽1.5g、螺旋藻多肽1.3g、生姜肽1.5g、低聚木糖4.5g、低聚果糖3.5g。
醒酒复合肽的制备方法，其步骤包括：按各原料所占重量百分数计量称取各种原料，混合均匀，得到醒酒复合肽。
Claims (8)
1.一种醒酒复合肽，按质量份数，其组成包括：甘草肽10-12份、绿豆肽10-15份、黑豆肽10-15份、黄豆肽8-12份、青豆肽8-10份、赤小豆肽8-10份、花生肽3-5份、核桃肽4-6份、玉米低聚肽1-2份、葛根肽3-5份、人参肽1-1.5份、灵芝胞外糖肽0.5-1.2份、海参肽1-2份、螺旋藻多肽1-1.5份、生姜肽1-2份。
2.根据权利要求1所述的一种醒酒复合肽，其特征在于：所述的醒酒复合肽中，各种原料的肽数均分子量为200-1500。
3.根据权利要求2所述的一种醒酒复合肽，其特征在于：所述的醒酒复合肽中，各种原料的肽数均分子量为400-800。
4.根据权利要求1至3任一项所述的一种醒酒复合肽，按质量份数，其组成还包括：低聚木糖3-6份、低聚果糖3-5份。
5.根据权利要求4所述的一种醒酒复合肽，按质量份数，其组成为：甘草肽10-12份、绿豆肽13-15份、黑豆肽12-15份、黄豆肽10-12份、青豆肽8-9份、赤小豆肽9-10份、花生肽4-5份、核桃肽4-5份、玉米低聚肽1-1.5份、葛根肽3-4份、人参肽0.8-1.5份、灵芝胞外糖肽0.5-1份、海参肽1.5-2份、螺旋藻多肽1.2-1.5份、生姜肽1-1.5份、低聚木糖4-5份、低聚果糖3-4份。
6.根据权利要求5所述的一种醒酒复合肽，按质量份数，其组成为：甘草肽12份、绿豆肽14份、黑豆肽13份、黄豆肽11份、青豆肽9份、赤小豆肽10份、花生肽5份、核桃肽4份、玉米低聚肽1.2份、葛根肽4份、人参肽1.2份、灵芝胞外糖肽0.8份、海参肽2份、螺旋藻多肽1.5份、生姜肽1.2份、低聚木糖4份、低聚果糖3份。
7.根据权利要求5所述的一种醒酒复合肽，按质量份数，其组成为：甘草肽11份、绿豆肽13份、黑豆肽15份、黄豆肽12份、青豆肽8份、赤小豆肽9份、花生肽4份、核桃肽5份、玉米低聚肽1份、葛根肽3份、人参肽1份、灵芝胞外糖肽1份、海参肽1.5份、螺旋藻多肽1.2份、生姜肽1份、低聚木糖5份、低聚果糖4份。
8.权利要求1-7任一项所述的一种醒酒复合肽的制备方法，其步骤包括：按各原料所占重量百分数计量称取各种原料，混合均匀，得到醒酒复合肽。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210141182.9A CN114568706A (zh) | 2022-02-16 | 2022-02-16 | 一种醒酒复合肽及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210141182.9A CN114568706A (zh) | 2022-02-16 | 2022-02-16 | 一种醒酒复合肽及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114568706A true CN114568706A (zh) | 2022-06-03 |
Family
ID=81770232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210141182.9A Pending CN114568706A (zh) | 2022-02-16 | 2022-02-16 | 一种醒酒复合肽及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114568706A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115251404A (zh) * | 2022-07-27 | 2022-11-01 | 彤博士健康产业河北有限公司 | 一种具有解酒护肝功能的营养粉及其制备方法 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1911437A (zh) * | 2006-06-28 | 2007-02-14 | 杨贻方 | 醒酒饮料 |
| CN105476030A (zh) * | 2015-12-15 | 2016-04-13 | 北京天肽生物科技有限公司 | 一种多功能复合低聚肽营养粉 |
| CN105886584A (zh) * | 2015-01-28 | 2016-08-24 | 张恒 | 一种葛根肽提取方法 |
| CN107518133A (zh) * | 2017-09-29 | 2017-12-29 | 芜湖绿而优农业科技有限公司 | 一种解酒护肝花茶及其制备方法 |
| CN108753874A (zh) * | 2018-06-21 | 2018-11-06 | 哈尔滨华藻生物科技开发有限公司 | 一种小分子活性肽新型螺旋藻粉的制备方法 |
| CN108813613A (zh) * | 2018-06-04 | 2018-11-16 | 国农农业股份有限公司 | 一种橄榄枳椇子肽醒酒护肝营养粉及其制备方法 |
| CN111358009A (zh) * | 2020-03-16 | 2020-07-03 | 赵秋萍 | 一种植物肽及其制备方法和应用 |
| CN111357865A (zh) * | 2020-04-20 | 2020-07-03 | 吉林省特医食品生物科技有限公司 | 红色食品复合小分子肽及在机体氧化损伤修复中的应用 |
| CN112715957A (zh) * | 2020-12-04 | 2021-04-30 | 广州音波美健康生物科技有限公司 | 一种解酒护肝的生物小分子肽组合物及其制备方法 |
-
2022
- 2022-02-16 CN CN202210141182.9A patent/CN114568706A/zh active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1911437A (zh) * | 2006-06-28 | 2007-02-14 | 杨贻方 | 醒酒饮料 |
| CN105886584A (zh) * | 2015-01-28 | 2016-08-24 | 张恒 | 一种葛根肽提取方法 |
| CN105476030A (zh) * | 2015-12-15 | 2016-04-13 | 北京天肽生物科技有限公司 | 一种多功能复合低聚肽营养粉 |
| CN107518133A (zh) * | 2017-09-29 | 2017-12-29 | 芜湖绿而优农业科技有限公司 | 一种解酒护肝花茶及其制备方法 |
| CN108813613A (zh) * | 2018-06-04 | 2018-11-16 | 国农农业股份有限公司 | 一种橄榄枳椇子肽醒酒护肝营养粉及其制备方法 |
| CN108753874A (zh) * | 2018-06-21 | 2018-11-06 | 哈尔滨华藻生物科技开发有限公司 | 一种小分子活性肽新型螺旋藻粉的制备方法 |
| CN111358009A (zh) * | 2020-03-16 | 2020-07-03 | 赵秋萍 | 一种植物肽及其制备方法和应用 |
| CN111357865A (zh) * | 2020-04-20 | 2020-07-03 | 吉林省特医食品生物科技有限公司 | 红色食品复合小分子肽及在机体氧化损伤修复中的应用 |
| CN112715957A (zh) * | 2020-12-04 | 2021-04-30 | 广州音波美健康生物科技有限公司 | 一种解酒护肝的生物小分子肽组合物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 包卫洋 等: "海洋生物活性肽的研究与产业化", 海洋出版社, pages: 93 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115251404A (zh) * | 2022-07-27 | 2022-11-01 | 彤博士健康产业河北有限公司 | 一种具有解酒护肝功能的营养粉及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102090692B (zh) | 一种牡蛎多肽抗疲劳饮料及其制备方法 | |
| CN108785331B (zh) | 一种具有气血双补的组合物及其制备方法和应用 | |
| CN114631565A (zh) | 一种酒前饮品及其制备方法 | |
| CN114568706A (zh) | 一种醒酒复合肽及其制备方法 | |
| CN106047974A (zh) | 一种具有抗氧化、抗疲劳活性的海马多肽及其制备工艺 | |
| CN114214366B (zh) | 一种预防和治疗贫血的小肽粉和血红素之肽红复方药物及其制备方法和应用 | |
| CN101524167A (zh) | 一种小分子海参粉及小分子海参粉胶囊 | |
| WO2021082311A1 (zh) | 一种具有辅助降血糖功能的豌豆肽及其制备方法 | |
| CN113455602A (zh) | 一种植物酵素肽饮品及其制备方法 | |
| CN117137131A (zh) | 一种黄精枸杞酵素粉及其制备的方法 | |
| JP2013133313A (ja) | 非アルコール性脂肪性肝疾患および／または非アルコール性脂肪肝炎の治療薬 | |
| CN111165750A (zh) | 一种利用发酵技术制备海参花粉剂的方法 | |
| JP2010155789A (ja) | 肝機能障害改善剤 | |
| CN106333357A (zh) | 海参肠螺旋藻颗粒冲剂及其制备方法 | |
| CN106072668A (zh) | 排毒养颜的保健品及其制备方法 | |
| CN111436618A (zh) | 百香果多肽组合物及其制备方法 | |
| CN117256863B (zh) | 一种多维提高血红蛋白水平的血肽复合口服液及制备方法 | |
| KR102535328B1 (ko) | 흑후추 추출물을 함유하여 글루타치온의 체내 흡수율을 높인 건강기능 식품용 조성물 및 이의 제조방법 | |
| CN116392546B (zh) | 一种抗疲劳和补肾阳的植物发酵液及其制备方法与应用 | |
| KR102165643B1 (ko) | 표고버섯 당화농축액, 이를 이용한 표고버섯 당화농축분말 및 이의 제조방법 | |
| CN106106953A (zh) | 苦荞多肽茶及其制备方法 | |
| CN116035204B (zh) | 一种食用菌提取物发酵型能量补充食品及制备方法 | |
| CN115057921B (zh) | 一种灰海马抗氧化抗疲劳活性胶原蛋白肽及规模化制备方法 | |
| CN115413708B (zh) | 一种具有抗氧化功能的酸奶、制备方法及应用 | |
| CN1127913C (zh) | 一种调节免疫功能的营养保健品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |